EVMN

Evommune, Inc.

$13.21 -0.30 (-2.22%) At close · Jul 10

Market Cap

$475.80M

36,018,372

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-06-29	—
8-K	2026-06-02	—
10-Q	2026-05-07	2026-03-31
8-K	2026-05-07	—
DEF 14A	2026-04-21	—
8-K	2026-04-13	—
10-K	2026-03-05	2025-12-31
8-K	2026-03-05	—
8-K	2026-02-13	2026-02-12
8-K	2026-02-10	—
8-K	2025-12-11	—
10-Q	2025-12-11	2025-09-30
8-K	2025-11-07	—

Showing 1–13 of 13 filings

Key facts CIK 2044725 CUSIP 30054Y107 13F (30d) 1 filings 1 filers Visit website Investor relations